ABG vs REYN

ABG exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust accounting strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears undervalued relative to its Graham Number of $349.14 and intrinsic value of $801.22, trading at $238.04, but elevated leverage and weak technicals weigh on sentiment. Solid profitability metrics, double-digit revenue and earnings growth, and strong ROE contrast with insider selling and a bearish technical trend. Analysts concur with a 'hold' rating, aligning with mixed signals between value and sentiment.

REYN exhibits a stable financial profile with a Piotroski F-Score of 6/9 and a healthy current ratio of 1.93, though it lacks a definitive Altman Z-Score. While the company is significantly more profitable and less levered than its sector peers, it suffers from stagnant revenue growth (1.40%) and slightly negative earnings growth (-2.30%). The stock is currently trading at a premium to both its Graham Number ($18.57) and Intrinsic Value ($10.01), suggesting limited valuation upside. The investment case rests primarily on its 4.12% dividend yield and consistent earnings beat track record, offset by a bearish technical trend.